Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7024891 | PMC |
| http://dx.doi.org/10.1159/000504217 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A Case of Elephantiasic Pretibial Myxedema Successfully Treated With Intralesional Triamcinolone Acetate.
Cureus
September 2022
Radiology, Shri Vinoba Bhave Civil Hospital, Silvassa, IND.
Article Synopsis
- Graves' dermopathy is a skin condition related to Graves' disease, highlighted by the buildup of glycosaminoglycans in the skin's deeper layers.
- Most cases of pretibial myxedema resolve on their own, but some can cause significant damage.
- Conventional treatment includes topical steroids, though intralesional steroids, like triamcinolone acetate, have shown effective results in some cases.
Treatment of Elephantiasic Pretibial Myxedema With Rituximab Therapy.
Cutis
February 2022
Keck School of Medicine, University of Southern California, Los Angeles. Drs. Choi, Wysong, and Crew are from the Department of Dermatology. Dr. Christianakis is from the Department of Rheumatology.
Elephantiasic Pretibial Myxedema.
J Cutan Med Surg
May 2022
26634 Section of Dermatology, Department of Medicine, University of Calgary.
Edematous lower extremities with overlying verrucous plaques.
JAAD Case Rep
February 2021
Department of Dermatology, the University of Texas Medical Branch, Galveston, Texas.
Successful therapeutic approach in a patient with elephantiasic pretibial myxedema.
An Bras Dermatol
August 2020
Graduate and Post-Graduate Program in Dermatology, Faculdade Suprema, Juiz de Fora, MG, Brazil.
Localized pretibial myxedema is a dermopathy whose treatment is a challenge in dermatology, occurring in 0.5-4% of patients with Graves' disease. This autoimmune thyroid condition stimulates the production of hyaluronic acid and glycosaminoglycans that are deposited particularly in the pretibial region.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!